The immunoglobulin heavy chain intronic transcriptional enhancer (E/t) Is part of a complex cls-regulatory DNA region which has notably been shown to modulate V(D)J rearrangements of associated variable gene segments. We have used recombination substrates comprised of the E/i enhancer together with various lengths of additional downstream n sequences to assess the Individual contribution of those sequences to the V(O)J recombinational regulatory activity. Surprisingly, in the absence of large amounts of /t sequences, substrate rearrangements were not detected In Southern blot analyses of the lymphoid tissues from independent transgenic mice, but were readily detectable following transfectlon into cultured pre-B cells. A short \i segment which Includes matrix association regions (MARs) was not sufficient to restore high levels of rearrangements within the reporter transgenes. However, additional experiments demonstrated that the fi sequences are dispensable for V(D)J recombination In transgenic thymuses, implying a suppresslve effect exerted by the vector sequences left in the transgenic Insert, when they are attached near the E/t regulatory region. This suppression of V(D)J recombination, which correlates with an hypermethylatlon of the transgenes, is discussed in view of previously reported transgenic and gene targeting experiments.
INTRODUCTION
Immunoglobulin (Ig) and T cell receptor (TCR) genes are similarly organized into variable and constant regions. In developing (pre-) B and T lymphocytes, Ig or TCR variable regions are assembled from separate V (variable), D (diversity) and J (joining) gene segments by a site-specific recombination system referred to as V(D)J recombinase (1, 2) . V(D)J recombination events are strictly controlled with respect to cell-type and cell-stage of development. This is thought to involve cis-acting regulatory elements that would modulate the accessibility of the different Ig/TCR gene loci and/or segments to the recombinase activity (3, 4) .
To characterize the regulatory elements which influence recombinational accessibility, a model system has been previously developed, in which a hybrid (TCR/3 variable region/Ig heavy [H] constant /t region) minilocus is introduced into an Abelson murine leukemia virus (A-MuLV) transformed pre-B cell line, or into fertilized mouse eggs to produce transgenic mice (5, 6) . Notably, it has been shown that the minilocus undergoes lymphoid-specific rearrangements in independent lines of transgenic mice, provided it contains a 1.1 kilobases (kb) fragment from the IgH /t gene region. In view of the correlation between V(D)J recombination and germline transcription of Ig/T-CR genes (7, 8) , it was significant that this fragment includes the IgH intronic transcriptional enhancer (E/i) (9) (10) (11) (12) . In accordance with these transgenic studies, targeted deletion or replacement of a DNA segment comprising of the E/t enhancer core and associated flanking sequences have recently been shown to impair V(D)J recombination events at the IgH gene locus (13, 14) .
The E/i enhancer core shows a complex arrangement of several different overlapping stimulatory and negative components (see 15,16 for reviews). Putative regulatory elements have additionally been localized in the E/t-flanking regions. Thus, matrix association regions (MARs) are present on both sides of E/x (17) . Presumably, the MARs constitute chromosomal loop anchorage elements and may facilitate the DNA-protein interactions required for establishing transcriptional competence (18) . Interestingly, DNA-binding sites for putative transcriptional suppressors) overlap with the Eft-associated MARs (19) . In addition, nucleotide conservation between mouse and human, remarkably high in the E/t enhancer, extends to the region comprised of the E/t 3' MARs and beyond. Transcription originating heterogeneously from this region has been proposed to contribute to the accessibility of the IgH gene locus for rearrangement (20, 21) .
The respective roles of the various E/t-associated and/or E/tflanking elements in the control of the V(D)J recombination process, as well as the exact mechanism(s) by which they may contribute to this regulation, remain to be determined. In this study, we have introduced recombination substrates carrying various amounts of E/t downstream sequences into the genome of transgenic mice or of A-MuLV-transformed pre-B cells. Analysis of substrate assembly demonstrates that V(D)J recombination proceeds efficiently in the absence of all IgH sequences located downstream of the 1.1kb E/i-containing fragment. However, our results also point out that prokaryotic *To whom correspondence should be addressed sequences can inhibit substrate recombination when located close to the E/t regulatory components.
MATERIALS AND METHODS

Cell culture
The derivation, growth, and characteristics of the thymidine kinase negative variant (tk~) of the 38B9 A-MuLV transformed pre-B cell line have been described previously (22) .
Construction of the recombination substrates
The construction of the cVTE, cVTC/i, and cVTEQt substrates have been described previously (6) . Substrate cVTE/t800 was constructed by ligating the 820 base pairs (bp) EcoRl-HincU fragment (nucleotides #3560 to #4383 in locus MUSIGCDO7/ GENBANK, accession* J00440) into the unique EcoRl site of construct cVTE, using EcoRl linkers. Within all constructs, the several types of V(D)J recombinase-mediated rearrangements that could theoretically occur by deletion are as described previously (6) .
Cell transfection and production of transgenic mice
The constructs were linearized with restriction enzymes Nrul and Pvul, which cut into the pMCS cosmid vector (23) , yielding inserts cVTE (11.4kb), cVTQi (20.2kb), cVTEQt (21.4kb), or cVTE/i800 (12.2kb). Insert VTE (8.8kb) was obtained after complete digestion of the cVTE construct with EcoRl and partial digestion with HindM. All inserts were purified on agarose gels, followed by passage over Elutip-d columns (Schleicher and Schuell). For cell transfection, 4X10 6 cells were co-electroporated (200V; 960/iF) with 25^g of insert plus 2.5/ig of linearized pSV2-Neo plasmid (24) , using a Gene pulser system (Bio-Rad). Cell transfectants were selected in G418 supplemented media (lmg/ml) and sub-cloned by limiting dilution before analysis.
Microinjection of insert DNA (2/tg/ml) into fertilized (C57BL/ 6XCBA/J) F2 eggs, identification of founder mice, production and characterization of the transgenic lines were carried out as (25) ; the E/i 300 probe was a 300bp Pstl-EcoRl fragment containing the 3' region of the mouse IgH intronic enhancer (10) . Percentage of DJ, V(D)J, and total substrate rearrangements were determined following densitometric analyses of hybridized filters on a Baf 1000 Imaging Plate Device (Fuji), as described previously (26) .
DNA PCR assays
DNA PCR assays to quantitatively analyze substrate rearrangements were as described (26), except for the following modifications: 1) 50ng of purified genomic DNA was used; 2) as a 3' primer to amplify the cVTE insert, we used an oligonucleotide located upstream of the E/x core enhancer (i.e. oligonucleotide IgE: 5'-CAGGGACTCCACCAACACCA-3').
RESULTS AND DISCUSSION
Sequences affecting rearrangement events in a recombination substrate A recombination substrate comprised of a TCR/3 variable minilocus linked to an IgH Qi constant region gene (Fig. 1 , cVTEC/t) has been shown previously to undergo site-specific rearrangements in lymphoid tissues of transgenic mice (6) . Moreover, substrate rearrangements were shown to be dependent on the presence of a cis-acting E/t-containing DNA fragment because identical transgenes missing this fragment ( These results do not preclude whether additional sequences (i.e. besides those in the enhancer core) can affect the rearrangement events within the reporter transgenes. Potential candidates include the regulatory elements in the sequences flanking both sides of E/i (see above). As a first step to address this issue, we have produced lines of transgenic mice using two related recombination substrates that carry various amounts of m sequences downstream of En (Fig.l: cVTE and cVTE/x800). For each line, substrate rearrangements were initially analyzed by Southern blot assays, using genomic DNA from transgenic tissues, as described previously (6, 26) ; genomic DNA from tissues of transgenic mice carrying the cVTEC/i or cVTC/t substrate was used as a control (see Materials and Methods for details on the transgenic lines used in this study). Representative results are reported in figure  2 , which shows hybridization of the J/31 probe to BgHl-EcoRldigested DNA from a lymphoid (thymus) and a non-lymphoid (kidney) tissue. Thymic DNA from mice carrying the cVTE, cVTE^800, or cVTQt substrate only contains the J/31 -hybridizing fragments that correspond to the unrearranged transgenes (lanes 5-10), whereas, as expected, thymic DNA from a control mouse carrying the cVTECji substrate contains additional fragments indicative of substrate D/3J/3 and V(3(D/3)J/3 rearrangements (lanes 1 and 2; these same patterns have also been detected in the spleen and lymph nodes of the individual mice-data not shown). The decrease of the endogenous fragment in thymuses as compared to the corresponding kidneys (due to TCR/3 rearrangements in most thymocytes) confirmed the expression of a functional V(D)J recombinase in thymocytes of all transgenic mice. In subsequent studies using quantitative DNA PCR assays to analyze substrate rearrangement (26; see also Materials and Methods), we failed to detect substrate D(3Jj3 or V/3(D/S)J/3 joins in transgenic thymus from all the cVTE lines and from two out of four cVTE/i800 lines; with these sensitive assays however, substrate rearrangements were readily detected at low level (less than 5 % of those found in the cVTEC/x controls) in the two remaining cVTE/t800 lines (Table 1 and data not shown). Taken together, these results indicate that high levels of substrate rearrangements occurred solely in the CVTEC/J transgenes; conversely, substrate rearrangements were inefficient not only in the cVTC/i transgenes, but also in the cVTE and cVTE/t800 transgenes as
|-cVTEC(i-||-(• )
<NRg. well. Along the same lines, we found no mRNAs transcribed from the cVTQi, cVTE, and cVTE/t800 transgenes in the thymus, whereas transcription of the cVTEQi transgenes was readily detectable (data not shown; see also 4, 6) .
The recombination potential of the various substrates was similarly evaluated following electroporation into the A-MuLVtransformed pre-B cell line 38B9tk~. Previous studies have established that introduced TCR D/S and J/3 (but not V/3) gene segments can readily be recombined in this cell line (5, 27) . Cellclones from individual transfection experiments were isolated as described in Materials and Methods and were analyzed by Southern blot assays. The comparison between parental (38B9tk~) and clone DNAs indicated that most clones had integrated intact copies of the transfected substrate. Representative and from independent cell-clones transfected with inserts cVTE^800, cVTE, cVTEC^. or cVTC/i were analyzed as described in Figure 2 . The arrows indicate the 6 6kb submolar fragment carrying substrate D|3J(3 rearrangements within the cVTE/i800, cVTE, and cVTECfi inserts. The additional submolar fragment seen in lane 4, the size of which is not compatible with site-specific rearrangements within the cVTE insert, is likely to carry aberrant substrate rearrangements, as described previously (5.27). results for three positive clones from each experiment are shown in figure 3 . Significantly, all cVTE/i800, cVTE, and cVTEC/i transfectants contain, in addition to the endogenous and unrearranged substrate fragments, roughly equivalent amounts of a submolar fragment that has the size predictive of D/3J/3 substrate rearrangements (lanes 1-6, 8-10 ). In contrast, the cVTC/i transfectants contain only the endogenous and unrearranged substrate fragments (lanes 11-13) . Using PCR assays, we have confirmed that substrate D/3J/3 joins are present in equivalent amounts in the cVTE/t800, cVTE, and cVTEC/i transfectants (at ~ ten times lower levels than in thymus of the cVTEQ: transgenic mice), but are absent in the cVTQi transfectants (data not shown). Together, these results imply that the E^-containing fragment is necessary to induce rearrangements within recombination substrates transfected into pre-B cells, which is in agreement with the results from previous transgenic experiments (6) . However, in marked contrast to what was observed in the lymphoid cells of the transgenic mice, E/t-positive substrates can undergo similar level of D/3J/3 rearrangements in transfected pre-B cells, irrespective of the presence or absence of the downstream IgH sequences.
The changeable potentials for V(D)J recombination of the cVTE and cVTE/i800 substrates was reminiscent of the block in transgene expression occasionally observed following microinjection of certain DNA into mouse pre-implantation embryos as opposed to transfection into more differentiated cells (28) . This selective inhibition of transgene expression has tentatively been attributed to the absence of natural introns or the presence of prokaryotic sequences in the microinjected insert (29) (30) (31) (32) . Whether either feature can also impair V(D)J recombination is not known. However, it should be noted that: i) significant amounts of intron/exon sequences were missing in the cVTE and cVTE/t800 constructs, as compared to the cVTEQ* construct, and ii) consequently, in the cVTE and cVTE/i800 inserts, vector sequences were brought nearer to the E/t regulatory region (see Fig. 1 and Methods). To assess the individual contribution of those sequences in our experimental system, we produced transgenic mice using an insert devoid of any sequences downstream of the 1.1kb E/x-containing fragment (Fig. 4 , left panel, top: VTE insert). Genomic DNA from thymus and kidney of fifteen mice born following VTE microinjections were digested with Bg[R and tested by Southern blot analysis, using the J/31 probe. When compared to a wild type mouse, the tissues of two animals (the 5.1 and 5.7 mice) contained additional J/31-hybridizing fragments which indicated that they carried the microinjected insert (Fig. 4, right panel) . In addition, DNA from the thymus (but not the kidney) of both mice contains discrete fragments of sizes expected to carry substrate D/3J/9 and V/3(D/3)J/3 rearrangements (see figure legend for details on the different fragments labelled in the assay). As determined following densitometric scanning of hybridized filters, the relative intensities of these fragments and of the corresponding fragments found in mice carrying the cVTEC/t substrate were in the same order of magnitude (within a factor of two difference; Fig. 4,  left panel, bottom) . Together, these results demonstrate that all IgH sequences located downstream of the 1.1 kb E/x-containing fragment (including the E/t 3' MARs) are dispensable for substrate rearrangement in thymus, although it should be stressed that our data do not rule out a role for MAR sequences in V(D)J recombination because the E/i 5' MARS are present in the VTE insert. Conversely, these results imply that the lack of V(D)J recombination within the cVTE transgenes was due to the vector sequences attached to the microinjected inserts. Because the same prokaryotic sequences did not avoid V(D)J recombination to occur at high frequency within the cVTEC/t transgenes (6; this study), we conclude that the m region in the cVTEC/x substrate somehow protects the transgenes against this suppressive effect. The suppression of recombination also observed within the cVTE/i800 transgenes indicates that the 820bp of E/t 3' flanking sequences are not sufficient for protection. Lack of substrate rearrangement correlates with hypermethylation of the transgenes DNA modification by methylation profoundly affects both chromatin structure and gene expression (see 33,34 for reviews). Moreover, recent studies have indicated that DNA methylation can inhibit the V(D)J rearrangement potential of various types of recombination constructs (35, 36) . We therefore investigated the methylation status of our substrates in transgenic tissues or in transfected pre-B cells, focusing especially on the E/icontaining region. In mammals, DNA methylation predominantly affects cytosine in CpG dinucleotides. The 1. lkb E/t-containing fragment encompasses seven CpG motifs, of which two (positions #2435 and #3234 in locus MUSIGCDO7/GENBANK, accession* J00440) coincide with the sites of distinct methylation-sensitive endonucleases. CpG* 2435 is placed within an HpaU restriction site; at the IgH locus, this site becomes demethylated with the activation of the E/i enhancer and the onset of B-cell differentiation (37) . CpG* 3234 is located at the border of a methylatable Sau3 AI restriction site that flanks the /tEl element; /*E1 is one of the stimulatory elements within the E/x enhancer known to bind nuclear factors in lymphoid cells (38, 39) .
Methylation of the two CpG dinucleotides in the recombination substrates was assessed by Southern blot analysis, using appropriate restriction endonuclease cleavage of genomic DNA and hybridization with specific probes (the strategy for these assays is depicted in Fig. 5A and 6A, respectively) .
For each type of construct, analyses of independent lines of transgenic mice and of independent cell-transfectants gave consistent results. Representative results are shown in figures 5B/5C and 6B. In thymus, dinucleotide CpG* 2435 was hypomethylated in the cVTEC/i transgenes, whereas it was hypermethylated in the cVTE and cVTE/*800 transgenes, as shown by the sensitivity or resistance to cleavage of the relevant HpaU restriction site (Fig. 5B, compare lanes 1-3, 7-9 , 10-12); it is of note that the endogenous HpaU site was resistant in thymus, a result in agreement with previous findings in murine T cell lines (37) . Using similar assays, hypomethylation at the same site within the transgenes was observed in thymus of the 5.1 mouse carrying the VTE insert, but not in those of mice carrying the cVTQi insert (data not shown). In contrast, in pre-B cell-transfectants, a roughly equivalent profile of CpG methylation was observed among the various E^-containing substrates. Thus, in both the cVTEC/x or cVTE/i800 substrates, the HpaU site which encompasses CpG* 2435 was relatively resistant to cleavage (Fig. 5C ), implying the overall methylation of this sequence in the 38B9 transfectants. Interestingly however, submolar amounts of the BglU-HpaU (0.6kb) J/S-hybridizing fragment observed in DNA from the cVTECft and cVTE/i800 transfectants (lanes 3 and 6) were not detected using the enhancerless cVTQt transfectants (not shown) suggesting that a low level of CpG* 2435 hypomethylation prevails within the E/icontaining substrates. Analysis of dinucleotide CpG* 3234 using Sau3 Al-digested thymic DNA also yielded consistent results. For example, the relative accessibility of cleavage of the Sau3 AI site flanking the mEl element indicated that CpG* 3234 was hypomethylated in the cVTEC/t and VTE transgenes and, conversely, more methylated in the cVTE and cVTE/t800 transgenes (Fig. 6B, lanes 4-6, 7-9 , 10-12, and data not shown). Note that the endogenous site was accessible to Saui Al-cleavage in the thymus (see for example lanes 1-3), indicating that CpG* 3234 , in contrast to CpG' 2435 , is prone to hypomethylation in this organ (however, both dinucleotides in the transgene and in the endogenous IgH gene were hypermethylated in kidneys-data not shown). In summary, an increased level of CpG methylation within the E/i-containing fragment is specifically observed in the cVTE and cVTE/i800 versus the cVTEQt and VTE transgenes. Further analyses suggested that in thymus the 5' D/3 region of the cVTE and cVTE/x800 transgenes was also hypermethylated when compared to that of the cVTEQi transgenes (C.Fernex, unpublished data). Together, these results are best explained assuming that the presence of the prokaryotic sequences in the vicinity to the Ejiregulatory elements (and/or the upstream variable gene segments) induces a de novo methylation of the flanking regions within the microinjected substrates which somehow leads to a block of V(D)J rearrangement, although a direct effect of the prokaryotic sequences on V(D)J rearrangement, followed by incidental methylation of the transgenes, cannot formally be ruled out (see also below). Because methylation patterns are essentially established in a series of dynamic changes over the course of gametogenesis and early embryogenesis (40) , it is conceivable that important variations in the level of CpG methylation of the various inserts, and therefore in the potential of V(D)J recombination, may occur when they are introduced into preimplantation embryos. The significant level of CpG methylation observed among the various recombination substrates introduced into more differenciated cells, such as the 38B9 pre-B cells, may reflect the tendency of cultured cell-lines to progressivly methylate nonessential genes (41) , rather than a prokayotic-induced effect.
A variety of transgenes have been described which display lack of expression and concomitant CpG hypermethylation. In several instances however, only one or few transgenic lines carrying the same construct were affected, suggesting that the site of integration, and not the transgene itself, was the target for the observed modifications (see 42,43 for examples). In contrast, our hypothesis that the prokaryotic sequences target the epigenetic changes and the suppressive effect on V(D)J recombination is reinforced by the findings of hypermethylation and coincidental lack of rearrangements within two related (i.e. cVTE and cVTE/i800) substrates in several independent transgenic mouse lines. In this regard, our findings parallel the behaviour of another recombination substrate, the pHRD construct (44, 45) . This construct was hypermethylated and concurrently inert for V(D)J recombination in all independently derived transgenic mouse lines, whereas it was competent for rearrangement when transfected into pre-B cells. The mechanism of hypermethylation was apparently mediated through a single strain-specific modifier (Ssm-1) active in a C57BL/6 strain background. Likewise, the pHRD construct carries sequences of prokaryotic origin near its variable-gene-segment and E/t-enhancer components. Taking the view that methylation may constitute a system for neutralizing invading foreign DNA (46) , it is tempting to speculate that our transgenes may also be controlled by the Ssm-1 (the transgenic lines were maintained by crossing with [C57BL/6xCBA] Fl mice) or related modifier(s) directly involved in such a neutralizing mechanism. The generality of this phenomenon is further suggested by the suppressive effect on immunoglobulin light chain kappa (\ghx) rearrangements, following insertion of the bacterial Neo gene downstream of the IgLx intron enhancer (47) .
Evidence has been presented which implies that methyl CpGs may either directly interfere with the binding of specific transactivating factors or, alternatively, be bound by nuclear proteins which indirectly induce an inaccessible DNA conformation (33, 34) . Conceivably, either direct and/or indirect mechanisms can account for the inhibition of V(D)J recombination that we observed by affecting the access to their target sequences of critical diffusable factor(s), such as V(D)J recombinase component(s) or E^ trans-activator(s), and/or by affecting putative interactions between such factors. The suppressive effect might result from the spreading of the prokaryotic-induced methylation into the flanking eukaryotic sequences within the transgenic substrates, a model that bears similarities with variegating positional effects (48) . In the cVTEQi transgenes, the spreading could then be limited either passively by the length (about 10kb) of the IgH Qt-containing region or actively by some ill-defined element(s) present in this region (49, 50) . Structural features in DNA of non-vertebrate origin, such as the content of CpG, may contribute further to the suppressive effect. In fact, the first lOObp of pMCS vector sequences attached to the 3' side of our constructs-a part of the Tn3 transposon of E.coli-include 8 CpGs which is higher than the average 1/100 ratio characteristic of the mammalian genome (51) . Moreover, they also contain a sequence homologous to the murine R repetitive element. Interestingly, sequences homologous to a related (Bl) repetitive element have been described in negatively acting elements at the Igx and TCRa loci (52) .
Recently, gene targeting experiments have been used to investigate Ig transcriptional and/or recombinational cis-acting elements. Most of the experimental approaches resulted in the replacement of the regulatory element(s) in the murine genome by a selectable gene or by recombination target sequences of nonvertebrate origins (14, 47, (53) (54) (55) . Our data point out that the mere insertion of such sequences may not be neutral with respect to the chromatin structure and recombinational accessibility of the targeted region. This may explain, at least in part, the quantitative differences seen when analyzing the consequences on V(D)J recombination of targeted deletion versus targeted replacement of enhancer-containing DNA fragments (13, 14, 47) .
